Intranasal type I interferon treatment is beneficial only when administered before clinical signs onset in the SARS-CoV-2 hamster model
在 SARS-CoV-2 仓鼠模型中，仅在临床症状出现之前使用鼻内 I 型干扰素治疗才有益
期刊:PLoS Pathogens
影响因子:5.5
doi:10.1371/journal.ppat.1009427
Pierre Bessière, Marine Wasniewski, Evelyne Picard-Meyer, Alexandre Servat, Thomas Figueroa, Charlotte Foret-Lucas, Amelia Coggon, Sandrine Lesellier, Frank Boué, Nathan Cebron, Blandine Gausserès, Catherine Trumel, Gilles Foucras, Francisco J Salguero, Elodie Monchatre-Leroy, Romain Volmer
